Estimation of Population Pharmacokinetic Parameters in the Presence of Non-compliance

By Mu Song   Ludden Thomas M.  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 30, Iss. 1, 2003-02 ,pp. : 53-81

Springer Publishing Company

Access to resources Recommend Favorite

Using Pharmacokinetic- Pharmacodynamic Relationships to Predict the Effect of Poor Compliance

By Boissel J-P.   Nony P.  

Clinical Pharmacokinetics, Vol. 41, Iss. 1, 2002-01 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite

Improving Pharmacokinetic–Pharmacodynamic Models of Muscle Relaxants Using Potentiation Modelling

By Eleveld Douglas   Proost Johannes   Haes Ann   Wierda J.  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 32, Iss. 1, 2005-02 ,pp. : 143-154

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacoeconomic Impact of Non-Compliance with Statins

By Andrew M. Peterson   William F. McGhan  

PharmacoEconomics, Vol. 23, Iss. 1, 2005-01 ,pp. : 13-25

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetics of Haloperidol Using Routine Clinical Pharmacokinetic Data in Japanese Patients

By Yukawa E.  

Clinical Pharmacokinetics, Vol. 41, Iss. 2, 2002-01 ,pp. : 153-159

Adis International

Access to resources Recommend Favorite